Bristol Myers Squibb Co. (NYSE:BMY) on 06/15/2022 declared a dividend of $ 0.5400 per share payable on August 01, 2022 to shareholders of record as of July 01, 2022.
Bristol Myers Squibb Co. (NYSE:BMY) has paid dividends since 1900, has a current dividend yield of 2.9641828537% and has increased its dividends for 12 successive years.
Bristol Myers Squibb Co.'s market cap is $ 155,144,893,680 and has a PE ratio of 0.00. The stock price closed yesterday at $ 72.87 and has a 52 week low/high of $ 53.22 and $ 78.61.
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.
For more information on Bristol Myers Squibb Co. click here.
Bristol Myers Squibb Co. current dividend information as per the date of this press release is:
